Goodwin Biotechnology Inc. and Hyprocell LLC Announce Collaboration
Collaboration will streamline cGMP manufacturing services
PLANTATION, Fla. and BRANFORD, Conn., April 28 /PRNewswire/ --Goodwin Biotechnology Inc., a full service contract biomanufacturing company, and Hyprocell LLC, a clinical cell line development services company, jointly announced today their collaborative agreement to create a business model enabling customers to access their one stop shop services.
The collaboration will enhance and strengthen the clinical development services integrating cDNA synthesis, cloning into mammalian expression vector, transfection, clone selection and stable cell line development seamlessly with cell banking, upstream/downstream process development and GMP manufacturing. Through this agreement customers will have smooth transition from creating high producing stable cell lines to GMP manufacturing gram quantities of antibodies and recombinant proteins in a much shorter time frame.
"Most of our customers are looking for one-stop shop type of CMO services and Hyprocell is a perfect partner to collaborate with to satisfy the market need," said Bansi Bhan, CFO, and interim CEO at Goodwin Biotechnology. "Hyprocell has the cutting edge technology and yet offers small company innovation and flexibility that we are looking for in a successful collaboration."
"We are excited about collaborating with Goodwin Bio, a company dedicated to delivering high quality clinical trial materials on time," said Pitchai Sangan, PhD., President and CEO of Hyprocell. "Our own Modular Flowcytometer is capable of isolating a single high producing cell out of millions of cells thus shortening the timeframe. Our Molecular Biology services integrated with Goodwin Bio's superior cGMP capability will accelerate clinical development programs."
About Goodwin Biotechnology Inc.:
Goodwin Biotechnology Inc. (GBI) located in Plantation, FL, is a full service contract biomanufacturing company and specializes in process development, cGMP production of protein based therapeutics and bioconjugation for pre-clinical and early phase clinical trials. The products manufactured by GBI are being used in clinical trials and the Company has assisted in the preparation of dozens of IND filings for various clients. GBI caters small to midsize biotech companies, universities, cancer research institutes and various branches of the U.S. Government.
About Hyprocell LLC:
Hyprocell, located in Branford, CT, is a company that offers customized services to biotechnology companies to enhance their clinical cell line development. The company has cell biologists with several years of experience using various molecular biology tools and techniques in cloning, designing expression constructs, developing transient and stable expression of antibodies and other proteins in various types of cell lines. Hyprocell caters to universities, biotechnology and pharmaceutical Industry.
For more information, please contact:
Hyprocell: (203) 747-1693; [email protected]
Goodwin Bio: (954) 327-9634; [email protected]
SOURCE Goodwin Biotechnology Inc.
Share this article